Robert G Gish Consultants

01/07/2026

🌍 I am honored to invite my network to join a timely discussion on Hepatitis B Updates: New Guidelines & Cures 🧬
📅 Live on Thursday, January 15, 2026
⏰ 7 pm ET / 4 pm PT
▶️ http://chmconnect.org/chb0115a-cp

🎓 Dr. Joseph Lim, from Yale School of Medicine and Director of the Yale Viral Hepatitis Program, will share insights into the latest progress toward curative therapies and what they mean for patients, caregivers, clinicians, and advocates.

💬 This is a unique opportunity to ask questions directly to an expert who has cared for people living with hepatitis B for over 20 years and is advancing global understanding of HBV management and cure science.

⚠️ Hepatitis B remains a leading cause of liver cancer, especially in African and Asian communities, and breakthroughs in care could reshape outcomes for millions worldwide.

🤝 I hope you’ll join us for this important conversation.
🆓 Register today—it’s free and open to all!

01/05/2026

Sharing an eye-opening episode of The Public Health Millennial: Why Prevention Always Comes Last in Public Health with Thelma Thiel 🌍💡

In this powerful conversation, Thelma breaks down why public health systems often prioritize treatment over prevention — even though stopping problems before they start could save so much suffering and cost. The discussion covers funding gaps, the tough realities of public health work, and why prevention deserves to be front and center 💬🧠
thephmillennial.com

📺 Check it out here: https://www.youtube.com/watch?v=k8CiFATHaRE

Omari Richins, MPH of Public Health Careers podcast talks with Thelma Thiel. In this conversation, Thelma Thiel shares her personal journey of loss and advoc...

01/02/2026

Happy New Year!🎉
And a new article to share with you🙌
https://onlinelibrary.wiley.com/doi/10.1111/jvh.70122

I think it is safe to say that hepatitis B virus prevalence in the US is up to 2.4 million from data in slides and publications. Read more in the link and please share!

Accurate estimates of the prevalence of chronic hepatitis B virus (HBV) in the United States (US) are necessary for policy makers and community-based organisations to make informed decisions regardin...

12/08/2025

I spoke with NBC 7 San Diego on Friday regarding the CDC advisory panel change for universal hepatitis B vaccine recommendation. I also stand firmly with the statement below from the Hepatitis B Foundation

"Eliminating the HBV vaccine dose at birth and creating more barriers for getting the vaccine means more newborns and children will be infected. Time will tell how many more babies and children will now become infected and ultimately - needlessly - die from liver disease and/or liver cancer as a result of these new recommendations.

The hepatitis B vaccine is the first known anti-cancer vaccine. It prevents liver cancer due to a chronic HBV infection. Any increase in this vaccine-preventable disease will be unforgivable.

Finally, we want to add there is now overwhelming evidence of the safety and effectiveness of the HBV vaccines in current use. Why some say otherwise is unclear to us. There are now decades of evidence about the safety and efficacy of the HBV vaccine collected controlled studies. This data is available because billions of doses have been given worldwide.

Hundreds of millions of children and adults have been saved worldwide by the hepatitis B vaccine since was first approved almost 50 years ago. We cannot return to the dark ages."

For more than 30 years, the CDC has recommended a first dose of the hepatitis B vaccine within 24 hours of birth. NBC 7's Joey Safchik explains why some doctors are concerned about the advisory panel's decision.

11/25/2025

I’m excited to share that my new article has just been published! 📣📝
You can read it here:
https://link.springer.com/article/10.1007/s11901-025-00710-w?utm_source=springer_etoc&utm_medium=email&utm_campaign=CONR_11901_AWA1_GL_DTEC_054CI_TOC-211125&utm_content=etoc_springer_20251121

This piece is a good review on iRNA as well as A*O molecules to help jump start HBV cure. I’m grateful for the opportunity to contribute to the growing body of knowledge in this field. A huge thank-you to my co-author and colleagues who continue to inspire this work

We continue to help advance research and improve patient outcomes💙

Purpose of Review Chronic hepatitis B (HBV) infection remains a major global contributor to liver disease, yet current antiviral therapies infrequently achieve a functional cure. This review highlights emerging data on 2 novel agents that are designed to suppress viral antigen expression and potenti...

11/24/2025

In celebration of Wilson Disease Awareness Day on December 6 from 10:00am-11:00am EST, the Wilson Disease Association will hold a community webinar where you can learn more about our upcoming landmark Externally Led – Patient Focused Drug Development Meeting (EL-PFDD).

In this webinar you will:
• Meet the team preparing the Wilson disease community for the meeting and the video panelists
• Learn what to expect during the meeting
• Learn how you can participate by calling in live, answering live polling questions and sharing comments for discussion and to be included in the Voice of the Patient report

Make sure your voice is heard to help the FDA, researchers, clinicians and product developers make better informed decisions that affect the entire Wilson disease community! ✅

👉Registration link:
https://us02web.zoom.us/webinar/register/WN_pjPPEmPoScqu3xheQN-osg #/registration

11/21/2025

💙 New Webinar Available: Understanding Wilson Disease 💙

I’m excited to share our latest webinar, now available on YouTube, focused on improving awareness, diagnosis, and management of Wilson Disease — a rare but treatable genetic disorder that requires early and accurate detection.

🎓 In this session, you’ll learn:

- How Wilson Disease develops and why early recognition is critical
- Key signs and symptoms clinicians and families should watch for
- Current diagnostic tools and the challenges that delay diagnosis
- Updates on treatment options and long-term management
- Practical advice for patients, caregivers, and healthcare providers

▶️ Watch the full webinar here:
https://www.youtube.com/watch?v=9V6UUaBqn3o

Liver Q & A Webinar: Overview of Wilson Disease. The presenter was Robert Gish, MD with La Maestra Community Health Centers and UCSD Skaggs School of Pharma...

11/20/2025

Please join me and Dr. Kosh Agarwal during our upcoming webinar: “Highlights from the Delta Cure and AASLD 2025 Meetings: Progress in Hepatitis Delta Diagnostics and the Therapeutic Pipeline.”

🗓 December 15 at 9:00 AM EST / 3:00 PM CET
👉 Register here: https://us02web.zoom.us/webinar/register/WN_oLj14TFhTniGS1a9YWDVjg #/registration
🌐 Hosted by the Hepatitis B Foundation

We will be sharing key takeaways, new research updates, and what’s ahead for HDV diagnostics and emerging therapies. If you’re involved in liver health, advocacy, research, or patient support, you won’t want to miss this session!

✨ Join us and help spread the word!

11/18/2025

It's !

There are several ways you can get involved 👇

✔️ Join our webinar starting in an hour: https://bit.ly/43GArus
✍ Take our online quiz to learn why testing matters: https://bit.ly/whtwquiz
🌍 Add your organisation to our global map: https://bit.ly/whtwmap
📲 Download and share our free resources: heptestweek.org

By taking part in World Hepatitis Testing Week, you’re helping make hepatitis testing a global priority. Let’s create awareness and drive action together!

11/12/2025

Call for Late-Breaking Abstracts – Deadline: November 17, 2025

Hep-DART 2025 is now accepting Late-Breaking Abstracts!

If you have new, high-impact data or recent breakthroughs in hepatitis or antiviral research, this is your opportunity to present your findings to an international audience of experts in hepatology, virology, and drug development.
Submission Deadline: November 17, 2025
Conference Dates: December 7–11, 2025

Location: Hilton Hawaiian Village Waikiki Beach Resort, Honolulu, Hawai‘i

Late-breaking abstracts should include important, novel, or time-sensitive research that was not available at the time of the regular abstract submission deadline. Accepted abstracts will be featured in the Hep-DART 2025 scientific program and published in the official conference proceedings.

🔗 Submit Your Abstract: https://informedhorizonseducation.com/abstracts-hepdart-2025

🌐 Learn More: www.hepdart.com

Join me in Honolulu for Hep-DART 2025 as we discuss the future of hepatitis therapy and drug development in a collaborative and inspiring environment!

Informed Horizons Education (IHE), a 501(c)(3) non-profit company, was launched in 2019 in order to address important and unmet educational needs in professional and medical fields as pertaining to continued medical education, live programming, and online resources that will benefit professionals, c...

11/11/2025

An incredible session at AASLD The Liver Meeting marking the 60th anniversary of the discovery of the hepatitis B virus (HBV) — a truly historic milestone in liver health and global health progress!

It was an absolute honor to share the stage with Dr. Harvey Alter, Laureate and one of the pioneers whose groundbreaking work helped shape our understanding viral hepatitis 🙌

So much progress has been made over the past six decades — and yet, the journey toward elimination continues. Grateful to be part of a community that remains committed to advancing research, advocacy, and patient care for all those affected by HBV 💛💉

11/10/2025

AASLD attendees: Come see me today at 2pm for a special session on the 60th Anniversary of the Discovery of the Hepatitis B Virus in ballroom C

I had a very full weekend attending many excellent sessions and exploring the poster gallery! 🍎✨ It’s always inspiring to connect with so many dedicated professionals, advocates, and researchers who are advancing the field of liver health. Looking forward to learning, sharing, and collaborating to improve outcomes for patients everywhere 💪🩺